36462 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 13
17:13 UTC
|
BFAM
Bright Horizons Family Solutions
|
◎ Target | Toni Kaplan ★★★★☆ #462 | Underweight | $66.00→ $64.00-3.0% |
|
Oct 13
17:13 UTC
|
BEPC
Brookfield Renewable
|
◎ Target | Robert Kad ★★★☆☆ #1112 | Underweight | $42.00→ $37.00-11.9% |
|
Oct 13
17:13 UTC
|
BEP
Brookfield Renewable Partners
|
◎ Target | Robert Kad ★★★☆☆ #1112 | Overweight | $42.00→ $37.00-11.9% |
|
Oct 13
17:13 UTC
|
BCE
BCE
|
◎ Target | Lauren Bonham ★★★☆☆ #1598 | Equal Weight | $25.00→ $24.00-4.0% |
|
Oct 13
16:13 UTC
|
WAT
Waters
|
◎ Target | Dan Brennan not yet tracked | Buy | $475.00→ $515.00+8.4% |
|
Oct 13
16:13 UTC
|
VRNS
Varonis Systems
|
◎ Target | Shaul Eyal ★★★★★ #107 | Buy | $53.00→ $56.00+5.7% |
|
Oct 13
16:13 UTC
|
VMRK
Vivmark Residential Common Shares of Beneficial Interest
|
◎ Target | Brad Heffern ★★★★☆ #382 | Sec→ r Perform | $71.00→ $67.00-5.6% |
|
Oct 13
16:13 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Brad Heffern ★★★★☆ #382 | Sec→ r Perform | $40.00→ $37.00-7.5% |
|
Oct 13
16:13 UTC
|
TXG
10x Genomics
|
◎ Target | Dan Brennan not yet tracked | Hold | $47.00→ $70.00+48.9% |
|
Oct 13
16:13 UTC
|
TMO
Thermo Fisher Scientific
|
◎ Target | Dan Brennan not yet tracked | Buy | $675.00→ $760.00+12.6% |
|
Oct 13
16:13 UTC
|
TEAM
Atlassian
|
◎ Target | Raimo Lenschow ★★★★★ #301 | Overweight | $172.00→ $222.00+29.1% |
|
Oct 13
16:13 UTC
|
SUI
Sun Communities
|
◎ Target | Brad Heffern ★★★★☆ #382 | Outperform | $148.00→ $140.00-5.4% |
|
Oct 13
16:13 UTC
|
SPXC
SPX Technologies
|
◎ Target | Joseph O'Dea not yet tracked | Overweight | $250.00→ $243.00-2.8% |
|
Oct 13
16:13 UTC
|
RVTY
Revvity
|
◎ Target | Dan Brennan not yet tracked | Buy | $130.00→ $175.00+34.6% |
|
Oct 13
16:13 UTC
|
QXO
QXO
|
◎ Target | Sam Reid ★★★☆☆ #1866 | Overweight | $18.00→ $16.00-11.1% |
|
Oct 13
16:13 UTC
|
QTRX
Quanterix
|
◎ Target | Dan Brennan not yet tracked | Hold | $3.00→ $3.50+16.7% |
|
Oct 13
16:13 UTC
|
QLYS
Qualys
|
◎ Target | Nick Yako not yet tracked | Hold | $170.00→ $200.00+17.6% |
|
Oct 13
16:13 UTC
|
NET
Cloudflare
|
◎ Target | Shaul Eyal ★★★★★ #107 | Buy | $355.00→ $375.00+5.6% |
|
Oct 13
16:13 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Brad Heffern ★★★★☆ #382 | Sec→ r Perform | $138.00→ $127.00-8.0% |
|
Oct 13
16:13 UTC
|
INVH
Invitation Home
|
◎ Target | Brad Heffern ★★★★☆ #382 | Sec→ r Perform | $31.00→ $29.00-6.5% |
|
Oct 13
16:13 UTC
|
ILMN
Illumina
|
◎ Target | Dan Brennan not yet tracked | Hold | $210.00→ $270.00+28.6% |
|
Oct 13
16:13 UTC
|
ESS
Essex Property Trust
|
◎ Target | Brad Heffern ★★★★☆ #382 | Outperform | $312.00→ $298.00-4.5% |
|
Oct 13
16:13 UTC
|
ELS
Equity Lifestyle Properties
|
◎ Target | Brad Heffern ★★★★☆ #382 | Outperform | $71.00→ $68.00-4.2% |
|
Oct 13
16:13 UTC
|
DHR
Danaher
|
◎ Target | Dan Brennan not yet tracked | Buy | $236.00→ $255.00+8.1% |
|
Oct 13
16:13 UTC
|
CPT
Camden Property Trust
|
◎ Target | Brad Heffern ★★★★☆ #382 | Sec→ r Perform | $111.00→ $101.00-9.0% |
|
Oct 13
16:13 UTC
|
BRKR
Bruker
|
◎ Target | Kyle Boucher ★★★★☆ #463 | Hold | $60.00→ $62.00+3.3% |
|
Oct 13
16:13 UTC
|
BLK
BlackRock
|
◎ Target | Mike Cyprys not yet tracked | Overweight | $1,479.00→ $1,468.00-0.7% |
|
Oct 13
16:13 UTC
|
AVTR
Avantor
|
◎ Target | Dan Brennan not yet tracked | Hold | $15.00→ $17.00+13.3% |
|
Oct 13
16:13 UTC
|
AVTR
Avantor
|
◎ Target | Tejas Savant not yet tracked | Equal Weight | $14.00→ $15.00+7.1% |
|
Oct 13
16:13 UTC
|
APPN
Appian
|
◎ Target | Raimo Lenschow ★★★★★ #301 | Underweight | $26.00→ $30.00+15.4% |
|
Oct 13
16:13 UTC
|
APP
AppLovin
|
◎ Target | Matthew Cost ★★☆☆☆ #2578 | Overweight | $450.00→ $400.00-11.1% |
|
Oct 13
16:13 UTC
|
APLE
Apple Hospitality REIT
|
◎ Target | Richard Hightower ★★★☆☆ #1621 | Equal Weight | $17.00→ $18.00+5.9% |
|
Oct 13
16:13 UTC
|
AMH
American Homes 4 Rent
|
◎ Target | Brad Heffern ★★★★☆ #382 | Outperform | $37.00→ $35.00-5.4% |
|
Oct 13
16:13 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Richard Hightower ★★★☆☆ #1621 | Overweight | $66.00→ $60.00-9.1% |
|
Oct 13
16:13 UTC
|
ADT
ADT
|
◎ Target | Greg Parrish ★★☆☆☆ #2571 | Equal Weight | $7.75→ $7.25-6.5% |
|
Oct 13
16:13 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Dan Brennan not yet tracked | Buy | $28.00→ $32.00+14.3% |
|
Oct 13
16:13 UTC
|
A
Agilent Technologies
|
◎ Target | Kallum Titchmarsh ★★★★★ #80 | Overweight | $175.00→ $190.00+8.6% |
|
Oct 13
16:13 UTC
|
A
Agilent Technologies
|
◎ Target | Dan Brennan not yet tracked | Buy | $180.00→ $196.00+8.9% |
|
Oct 13
15:13 UTC
|
WLK
Westlake
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Outperform | $95.00→ $74.00-22.1% |
|
Oct 13
15:13 UTC
|
OLN
Olin
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Sec→ r Perform | $20.00→ $16.00-20.0% |
|
Oct 13
15:13 UTC
|
OI
O-I Glass
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Sec→ r Perform | $8.00→ $7.00-12.5% |
|
Oct 13
15:13 UTC
|
NRIX
Nurix Therapeutics
|
◎ Target | Brian Abrahams ★★☆☆☆ #2338 | Outperform | $36.00→ $35.00-2.8% |
|
Oct 13
15:13 UTC
|
META
Meta Platforms
|
◎ Target | Jeffrey Wlodarczak ★★☆☆☆ #2563 | Buy | $790.00→ $930.00+17.7% |
|
Oct 13
15:13 UTC
|
LYB
LyondellBasell Industries
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Outperform | $72.00→ $68.00-5.6% |
|
Oct 13
15:13 UTC
|
GPK
Graphic Packaging
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Sec→ r Perform | $10.00→ $9.00-10.0% |
|
Oct 13
15:13 UTC
|
GEL
Genesis Energy
|
◎ Target | Elvira Scotto ★★★☆☆ #1486 | Outperform | $18.00→ $17.00-5.6% |
|
Oct 13
15:13 UTC
|
CE
Celanese
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Sec→ r Perform | $45.00→ $46.00+2.2% |
|
Oct 13
15:13 UTC
|
BMY
Bristol Myers Squibb
|
◎ Target | Mohit Bansal ★★★☆☆ #1225 | Equal Weight | $65.00→ $60.00-7.7% |
|
Oct 13
15:13 UTC
|
BALL
Ball
|
◎ Target | Arun Viswanathan ★★★☆☆ #1728 | Outperform | $77.00→ $73.00-5.2% |
|
Oct 13
15:13 UTC
|
AADX
Applied Aerospace & Defense
|
◎ Target | Ken Herbert not yet tracked | Outperform | $24.00→ $21.00-12.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.